작성일 : 16-03-16
AM Biotechnologies, LLC.
   http://am-biotech.com/

AM Biotechnologies, LLC develops synthetic affinity reagents called X-Aptamers for applications in research, diagnostics
and therapeutics.  X-Aptamers provide the performance of biologically-produced monoclonal antibodies but avoid many
of the problems associated with them.  Our scientists have extensive experience in the aptamer field and are also highly
skilled in nucleic acid chemistry, which includes the development of phosphoramidites and nucleotides that have highly
unique chemical functionalities.  The chemically-modified phosphoramidites developed by AM Biotechnologies also enhance
the performance of RNAi.  AM Biotech started operations in 2006 and is based in Houston, Texas.

AM Biotech Customers Include:
- Several major pharmaceutical companies (US and Europe)
- Biotechnology companies
- Universities (US and Canada)
- The National Institutes of Health (NIH)
- The National Aeronautics and Space Administration (NASA
- The UK Defence Science & Technology Laboratory (DSTL)

The following entities have generously provided support for research into X-Aptamers and/or thiophosphoramidites:
- The National Institutes of Health (NIH)
- The National Aeronautics and Space Administration (NASA)
- Defense Advanced Research Projects Agency (DARPA)
- The Bill & Melinda Gates Foundation